Exascale Labs director files with no holdings

Exascale Labs Holdings Inc. names director Kariv Shachar as a reporting person with no reported holdings or transactions yet.

Rhea-AI Filing Summary

Exascale Labs Holdings Inc. (XLAB) filed an initial statement of beneficial ownership for Kariv Shachar, who is identified as a director of the company. The filing reports no non-derivative or derivative holdings and no reportable transactions at this time.

Key Figures

Buy transactions: 0 transactions Sell transactions: 0 transactions Derivative transactions: 0 transactions +1 more

4 metrics

Buy transactions 0 transactions Number of reported purchases by Kariv Shachar on this Form 3

Sell transactions 0 transactions Number of reported sales by Kariv Shachar on this Form 3

Derivative transactions 0 transactions Number of option or other derivative transactions reported

Holding entries 0 holdings Non-derivative and derivative holdings reported for Kariv Shachar

Key Terms

ten percent owner

1 terms

ten percent owner regulatory

"is_ten_percent_owner: 0 indicates the person is not a ten percent owner"

FAQ

What does the Form 3 for XLAB report about Kariv Shachar?

The Form 3 lists Kariv Shachar as a director and reporting person of Exascale Labs Holdings Inc., with no securities holdings or transactions reported in this initial statement.

Are any XLAB shares reported as owned by Kariv Shachar on this Form 3?

No. The Form 3 indicates no reported non-derivative or derivative holdings for Kariv Shachar as of the filing, and there are no holding entries listed.

Does the XLAB Form 3 show any insider buying or selling by Kariv Shachar?

No. The Form 3 shows no buy or sell transactions by Kariv Shachar, with all transaction counts, including purchases, sales, and exercises, reported as zero.

Is Kariv Shachar a ten percent owner of XLAB according to this Form 3?

No. The reporting information classifies Kariv Shachar as a director only and does not mark them as a ten percent owner of Exascale Labs Holdings Inc.

Does the XLAB Form 3 mention any Rule 10b5-1 trading plan for Kariv Shachar?

No. The document-level indicator for Rule 10b5-1 plans is null, and there are no transactions or footnotes describing any trading plan for Kariv Shachar.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 12:40 PM Accepted by SEC EDGAR 09/08/2026 - 12:39 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kariv Shachar

(Last) (First) (Middle)

820 GESSNER ROAD, SUITE 332

(Street)

HOUSTON, TEXAS 77024

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/27/2026

3. Issuer Name and Ticker or Trading Symbol
Exascale Labs Holdings Inc. [ XLAB ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Shachar Kariv	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)